Carcinoma: all 6,718 studies
Page 26 of 68. Open to participants first (1,141), then studies with results posted, then the rest; newest registration first within each.
- A Study of Participants With Initially Unresectable Hepatocellular Carcinoma That is Treated With Atezolizumab and Bevacizumab Plus Transarterial ChemoembolizationCompletedNCT06503250
- Robotic Versus Laparoscopic Liver Resection for Hepatocellular CarcinomaCompletedNCT06496113
- Defining Musical Toxicity and Its Effect on Patient Well-beingWithdrawnNCT06494046
- a Neo-adjuvant Chemotherapy Immunotherapy in Resectable ESCC StudyActive, not recruitingNCT06472635
- A Study of PHN-010 in Patients With Advanced Solid TumorsTerminatedNCT06457997Phase 1
- Functional Near-Infrared Spectroscopy and Virtual Reality Relaxation Programs for Pain Management in Patients With CancerTerminatedNCT06456411Not applicable
- Combined Anti-IL6R and Anticoagulation Therapy in Advanced NPC PatientsActive, not recruitingNCT06442709Not applicable
- Comparison of Gd-EOB-DTPA-enhanced MRI and Contrast-enhanced Ultrasound for Measuring Tumor Size of Solitary Hepatocellular Carcinoma ≤ 5cm:A Retrospective StudyCompletedNCT06437457
- Lenvatinib vs Bevacizumab Plus ICIs and HAIC in Unresectable HCCCompletedNCT06435013
- Study of Avelumab and Tuvusertib in Participants With Advanced Urothelial Cancer That Has Progressed on Prior Anti-PD-(L)1 Therapy (JAVELIN DDRiver Bladder)WithdrawnNCT06424717Phase 2
- Observational Study of Muscle Invasive Urothelial Carcinoma Participants Treated With Adjuvant Nivolumab in FranceTerminatedNCT06421311
- The Dual Impact of Cirrhosis on Transplantation for Hepatocellular Carcinoma：a Two-center Retrospective Cohort Study in ChinaCompletedNCT06420791
- A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung CancerActive, not recruitingNCT06417814Phase 3
- Atezolizumab and Bevacizumab Combination Recommended in a Multidisciplinary Consultation Meeting in Caen for Hepatocellular Carcinoma (ABCHCaen)CompletedNCT06416683
- PBI-MST-01 (NCT04541108) Substudy MSD-03: Intratumoral Microdosing of Pembrolizumab Alone and With MK-0482 or MK-4830 in HNSCC or STSCompletedNCT06413095Early Phase 1
- Changhai Multimodal Esophageal Cancer CohortActive, not recruitingNCT06410677
- Research and Application for New Clinical Diagnosis and Treatment System for HBV Related HCC Liver TransplantationCompletedNCT06409507
- Prediction of Cervical Lymph Node Metastasis in Papillary Thyroid Carcinoma Based on Ultrasound and Cytological ImagesCompletedNCT06399159
- Testing the Addition of ASTX660 (Tolinapant) to the Usual Chemotherapy Treatment (Paclitaxel With or Without Bevacizumab) in Patients With Recurrent Ovarian CancerWithdrawnNCT06393751Phase 1/2
- Impact of Hepatectomy on HCC RecurrenceCompletedNCT06390228
- Pharmacokinetics, Biodistribution, Radiation Dose and Safety Study of 68Ga-NYM005 in PatientsCompletedNCT06389682Phase 1/2
- Study of Cemiplimab Alone or in Combination With Fianlimab and/or Other Experimental Agents in Adult Participants With Peri-operative Stage III/IV Cutaneous Squamous Cell Carcinoma (CSCC)WithdrawnNCT06384820Phase 2
- Discovering Urinary Protein Biomarkers for Hepatocellular Carcinoma in Chronic Hepatitis B PopulationActive, not recruitingNCT06379334
- Cabozantinib Treatment Prior to Cytoreductive Nephrectomy in Patients With Advanced or Metastatic Renal Cells CancerTerminatedNCT06377722Phase 2
- Optimization of Management for Sporadic Bilateral Renal Cell CarcinomaCompletedNCT06369519
- Methylation-specific PCR Test for Early Screening and Early Diagnosis of Nasopharyngeal CarcinomaCompletedNCT06367049
- Study of VG2025 Delivered Intraperitoneally in Patients With Advanced Solid Tumors With CarcinomatosisWithdrawnNCT06365918Phase 1
- Liver Transplantation for Hepatocellular Carcinoma Arising in Non-cirrhotic Liver: a Propensity Score-matched Retrospective Cohort Study of Two National DatabasesCompletedNCT06364839
- ASTX727 and Nivolumab in Squamous Cell Carcinoma of the Head and NeckWithdrawnNCT06357858Phase 1
- Massive Nasal Bleeding in Patients With NPC Received Curative RTCompletedNCT06348485
- A First-in-Human Study to Learn About How BAY3630942 is Distributed and Processed Inside the Body When Given After BAY3547922 and How Safe it is in People With Liver Cancer or Other Select Solid CancersCompletedNCT06345001Phase 1
- Pre-Transplant INCBB099280 for Hepatocellular Carcinoma (HCC)WithdrawnNCT06337162Phase 1
- The Study of the Validation of General Evaluation Score (GES) in the Prediction of Hepatocellular Carcinoma Risk Among Patients With Advanced Fibrosis and Cirrhosis Who Achieved Sustained Virological Response for Hepatitis C Virus After Direct Acting Antiviral DrugsActive, not recruitingNCT06325826
- Preoperative Inflammatory Markers Predict Postoperative Complications After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Colorectal CarcinomatosisCompletedNCT06318793
- A Study of Dostarlimab in Combination With Carboplatin-paclitaxel in Japanese Participants With Primary Advanced or Recurrent Endometrial CancerActive, not recruitingNCT06317311Phase 2
- Effectiveness and Safety of Lenvatinib Combined With Chinese Herbal Medicine for Patients With Unresectable Hepatocellular Carcinoma: A Real-world Study in ChinaCompletedNCT06315101
- Ex Vivo 3D-ultrasound for Oropharyngeal CancerCompletedNCT06314711Not applicable
- Pharmacogenetic of Doxorubicin in HCC.CompletedNCT06313047
- Carbonic Anhydrase IX Enzyme in Triple Negative Breast CarcinomaCompletedNCT06309459
- Study Comparing the Pharmacokinetics, Safety, and Efficacy of RPH-075 and Keytruda® in Patients With Malignant NeoplasmsCompletedNCT06307093Phase 1
- Prognostic Value of Performance Scores in Patients Undergoing Surgery for Upper Tract Urothelial CarcinomaCompletedNCT06305130
- Postoperative Adjuvant Immunotherapy for Hepatocellular Carcinoma: Risk Factor Analysis and Prognostic ModellingCompletedNCT06298123
- Adrenal Project: Clinical and Epidemiological Characterization of Adrenocortical Carcinoma in a Brazilian CohortCompletedNCT06279442
- The Diagnostic Accuracy of Advanced Imaging in Identifying Suspected Skin Cancer (Basal Cell Carcinoma) Around the EyesCompletedNCT06279143
- Lenvatinib Plus DEB-TACE With/Without FOLFOX-HAIC for Large HCC With PVTTCompletedNCT06265883
- Survival Analysis: TACE vs. Combination Therapy in HCCCompletedNCT06261138
- Oral Cavity Squamous Cell Carcinoma and Readmission: Rates, Causes, and Risk Factors.CompletedNCT06259838
- Intermittent Oral-esophageal Tube in Delayed Dysphagia After Radiotherapy for Nasopharyngeal CarcinomaTerminatedNCT06248840Not applicable
- Liver Resection for Patients With Hepatocellular Carcinoma and Clinically Significant Portal HypertensionCompletedNCT06245798
- Retrospective Study on the Prediction of Radiation-induced Brain Injury in Patients With Nasopharyngeal CarcinomaCompletedNCT06244394
- Is Desmoplastic Stromal Reaction Useful to Modulate Lymph Node Dissection in Sporadic Medullary Thyroid Carcinoma?CompletedNCT06243965
- Multi-institutional Analysis of Survival and Recurrence Patterns of Different Pathological Regression Types After Neoadjuvant Chemoradiotherapy or Radiotherapy for Esophageal Squamous Cell CarcinomaCompletedNCT06241079
- The Prognostic Value of Tertiary Lymphatic Structure in Esophageal Squamous Cell CarcinomaCompletedNCT06241066
- Association Between Pre-op Non-Selective Beta-Blockers and Hepatocellular Carcinoma Recurrence Post-Liver TransplantCompletedNCT06233708
- TACE Combined With Tyrosine Kinase Inhibitors and Tislelizumab in Unresectable Hepatocellular CarcinomaCompletedNCT06232759Phase 2
- Skin Tumor Biomarkers by Mass Spectrometry ImagingActive, not recruitingNCT06227416Not applicable
- SBRT Sequential Surufatinib Combined With Immunotherapy for Biliary Tract CarcinomaSuspendedNCT06199882Phase 2
- The Evaluation of the Effectiveness, Safety and Tolerability of Treatment, Using a PSMA-Lu177, in Patients with ACC- an Open, Non-commercial Clinical TrialWithdrawnNCT06199453Phase 2
- Atezolizumab Plus Bevacizumab Versus Sintilimab Plus Bevacizumab With TACE and HAIC in Unresectable Hepatocellular CarcinomaCompletedNCT06199297
- Study of Zanzalintinib (XL092) + AB521 and Zanzalintinib + AB521 + Nivolumab in Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC) or Other Advanced Solid Tumors (STELLAR-009)TerminatedNCT06191796Phase 1
- Real-world Experience of ICIs Plus Chemotherapy With or Without Radiotherapy for Advanced ESCC.CompletedNCT06190652
- Intermittent Oral-esophageal Tube Feeding in Delayed Dysphagia After Radiotherapy for Nasopharyngeal CarcinomaTerminatedNCT06189482Not applicable
- HAIC Combined Sintilimab for Liver Metastasis From Esophageal Squamous Cell CarcinomaCompletedNCT06184841Phase 1
- B7-Family Score in Urothelial CarcinomaCompletedNCT06169904
- Effect of Cervical Paraesophageal Lymph Node Metastasis Versus Supraclavicular Lymph Node Metastasis on the Overall Survival of Patients With Thoracic Esophageal Squamous Cell Carcinoma: An Observational StudyCompletedNCT06165094
- Evaluating the Use of Photodynamic Therapy to Treat Facial Cutaneous Squamous Cell Carcinoma in Situ (isSCC)CompletedNCT06159842Phase 2
- A Study of 1 8F-FDHT PET/MRIScans in Women With Breast CancerWithdrawnNCT06145399Early Phase 1
- Lenvatinib After Progression on Atezolizumab-bevacizumab in Hepatocellular CarcinomaActive, not recruitingNCT06138769Phase 2
- Exploring the Influence of Clinical Factors on the Prognosis of Papillary Renal Cell CarcinomaCompletedNCT06111560
- Autologous T Cells Lentivirally Transduced to Express L1CAM-Specific Chimeric Antigen Receptors in Treating Patients With Locally Advanced and Unresectable or Metastatic Small Cell Neuroendocrine Prostate CancerWithdrawnNCT06094842Phase 1
- A Clinical Trial for the Safety and Efficacy of CD-801 in Patients With Advanced Hepatocellular CarcinomaCompletedNCT06092112Early Phase 1
- Milademetan in Combination With Atezolizumab in Patients With Advanced Solid Tumors With CDKN2A LossWithdrawnNCT06090318Phase 1/2
- Testing the Addition of an Investigational Drug, Xevinapant, to Usual Radiation Therapy Plus Cisplatin/Carboplatin for Patients With Head and Neck CancerWithdrawnNCT06084845Phase 2
- Calcitonin in Needle Wash Using Electrochemiluminescence Method For Diagnosis Of Medullary Thyroid Carcinoma.CompletedNCT06067594
- Study to Evaluate TNG348 Alone and With a PARP Inhibitor in Patients With BRCA 1/2 Mutant or HRD+ Solid TumorsTerminatedNCT06065059Phase 1/2
- PBI-MST-01(NCT04541108) Substudy TAK-02: Intratumoral Microdosing of TAK-676 in HNSCCCompletedNCT06062602Early Phase 1
- Moesin Expression in Clear Cell Renal Cell CarcinomaCompletedNCT06055660
- Study of ALE.C04 in Patients With Head and Neck CancerTerminatedNCT06054477Phase 1/2
- Prognostic Value of Tumor Deposits for Patients With Papillary Thyroid CarcinomaCompletedNCT06051838
- Study of HLA-DR in Cell Cultures Isolated From Primary Squamous Cell CarcinomaStatus unknownNCT06041464
- The Effects of Oxycodone Versus Sufentanil on Pain and Inflammatory Response After TACECompletedNCT06041425Phase 4
- Deep Learning Image Reconstruction for Abdominal CT of Hepatocellular Carcinoma Compared With 3-TESLA MRICompletedNCT06037343
- Study of MT-8421 as Monotherapy and in Combination With Nivolumab in Patients With Selected Advanced Solid Cancer TypesTerminatedNCT06034860Phase 1
- Salivary Expression of SOX7 in Oral Squamous Cell Carcinoma: Diagnostic Accuracy StudyCompletedNCT06031337
- Sorafenib In Egyptian Patients With Hepatocellular Carcinoma.CompletedNCT06030895Not applicable
- DRP-104 (Glutamine Antagonist) in Combination With Durvalumab in Patients With Advanced Stage Fibrolamellar Carcinoma (FLC)Active, not recruitingNCT06027086Phase 1/2
- cOCT Versus LC-OCT for Diagnosing Basal Cell Carcinoma: a Diagnostic Cohort StudyActive, not recruitingNCT06024629
- Study of XNW5004 Tablet in Combination With KEYTRUDA® (Pembrolizumab) in Subjects With Advanced Solid Tumors Who Failed Standard Treatments (KEYNOTE F19)TerminatedNCT06022757Phase 1/2
- Interobserver Variability DesmoplasiaCompletedNCT06020612
- Complications and Recurrences After Mohs Micrographic Surgery and Slow MohsActive, not recruitingNCT06014619
- Surgical Resection for Hepatocellular CarcinomaCompletedNCT06013657
- Neoadjuvant Tislelizumab Plus Chemotherapy for Locally Advanced Oral/Oropharyngeal Cancer (NeoSPOT)Active, not recruitingNCT06009861Phase 2
- A Study Evaluating Atezolizumab and Bevacizumab Plus ADI-PEG 20 in Patients With Locally Advanced / Metastatic Hepatocellular CarcinomaWithdrawnNCT06006286Phase 1/2
- Phase 1 Study of 68Ga-R8760TerminatedNCT05999292Phase 1
- Surgical Treatment of Stage T3 Squamous Cell Carcinomas of the ScalpActive, not recruitingNCT05987579
- Mechanism of Gastric Signet Ring Cell Carcinoma Based on MicroproteomicsActive, not recruitingNCT05985577
- Hürthle Cell Carcinoma and Follicular Thyroid CarcinomaCompletedNCT05968196
- Olaparib and Alpelisib for Treatment of Metastatic Breast Cancer, A ComboMATCH Treatment TrialWithdrawnNCT05967286Phase 2
- Selective Omission of Sentinel Lymph Node Biopsy in Mastectomy for Ductal Carcinoma in Situ: Identifying Eligible CandidatesCompletedNCT05961280
- Diagnostic Performance of [18F]FES PET/CT for Axillary LN Metastasis in Invasive Lobular CarcinomaCompletedNCT05960201Phase 2